Aileron Therapeutics's market cap is currently ―. The company's EPS TTM is $-6.02; its P/E ratio is -0.24; Aileron Therapeutics is scheduled to report earnings on April 3, 2023, and the estimated EPS forecast is $-1.27. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -4.70M	$ -6.48M	$ -8.04M	$ -8.42M	$ -6.82M
EBITDA	$ -4.66M	$ -6.44M	$ -8.00M	$ -8.38M	$ -6.78M
Net Income Common Stockholders	$ -4.55M	$ -6.37M	$ -7.99M	$ -8.42M	$ -6.80M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 21.24M	$ 25.48M	$ 32.38M	$ 38.08M	$ 45.93M
Total Assets	$ 22.01M	$ 27.23M	$ 33.77M	$ 40.26M	$ 48.48M
Total Debt	$ 33.00K	$ 67.00K	$ 100.00K	$ 131.00K	$ 162.00K
Net Debt	$ -21.21M	$ -25.41M	$ -32.28M	$ -37.94M	$ -45.77M
Total Liabilities	$ 3.38M	$ 4.54M	$ 5.15M	$ 4.15M	$ 4.58M
Stockholders Equity	$ 18.62M	$ 22.70M	$ 28.62M	$ 36.11M	$ 43.90M
Cash Flow	-
Free Cash Flow	$ -4.41M	$ -6.97M	$ -5.68M	$ -7.80M	$ -6.25M
Operating Cash Flow	$ -4.41M	$ -6.97M	$ -5.68M	$ -7.80M	$ -6.25M
Investing Cash Flow	$ 4.76M	$ 4.18M	$ 5.86M	$ 11.65M	$ 2.25M
Financing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 1.00K

Currency in USD

Aileron Therapeutics Earnings and Revenue History

Income Statement >

Aileron Therapeutics Debt to Assets

Balance Sheet >

Aileron Therapeutics Cash Flow

Cash Flow >

Aileron Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing